Selective Inhibition of Na <sub>V</sub> 1.8 with VX-548 for Acute Pain
2023 · New England Journal of Medicine · 238 citations
https://doi.org/10.1056/nejmoa2209870
D
Darin Correll
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
119
Papers
1.6K
Citations
20
h-index
24
i10-index
Darin Correll is an academic researcher from Vertex Pharmaceuticals (United States). The author has contributed to research in topics: Anesthesia and Pain Management & Cardiac, Anesthesia and Surgical Outcomes & Pain Management and Opioid Use. The author has an h-index of 20, co-authored 102 publications.
ORCID: 0000-0003-2985-3448Papers by this author
worksKetamine Decreases Postoperative Pain Scores in Patients Taking Opioids for Chronic Pain: Results of a Prospective, Randomized, Double-Blind Study
2013 · Pain Medicine · 74 citations
https://doi.org/10.1111/pme.12086
Epidural analgesia compared with intravenous morphine patient-controlled analgesia: Postoperative outcome measures after mastectomy with immediate TRAM flap breast reconstruction
2001 · Regional Anesthesia & Pain Medicine · 59 citations
https://doi.org/10.1053/rapm.2001.26219
APS position statement on the use of placebos in pain management
2005 · Journal of Pain · 41 citations
https://doi.org/10.1016/j.jpain.2005.01.347
Suzetrigine, a Non-Opioid NaV1.8 Inhibitor With Broad Applicability for Moderate-to-Severe Acute Pain: A Phase 3 Single-Arm Study for Surgical or Non-Surgical Acute Pain
2025 · Journal of Pain Research · 38 citations
https://doi.org/10.2147/jpr.s509144
Suzetrigine, a Non-Opioid NaV1.8 Inhibitor for Treatment of Moderate-to-Severe Acute Pain: Two Phase 3 Randomized Clinical Trials
2025 · Anesthesiology · 34 citations
https://doi.org/10.1097/aln.0000000000005460
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat